Medico Reach
MARCH 24, 2023
Hence, new oncology market trends will set in as doctors and pharmaceutical companies work towards individualized treatment decisions. Immunotherapy To combat the deadly disease, numerous pharmaceutical companies are actively pursuing FDA approval, which reflects its enormous market potential. billion by 2028.
Medico Reach
MARCH 24, 2023
Hence, new oncology market trends will set in as doctors and pharmaceutical companies work towards individualized treatment decisions. Immunotherapy To combat the deadly disease, numerous pharmaceutical companies are actively pursuing FDA approval, which reflects its enormous market potential. billion by 2028.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Medico Reach
OCTOBER 17, 2022
million by 2028. Quite recently, the Food and Drug Administration (FDA) marked a historical moment when it approved Patient Specific Talus Spacer 3D-printed implants in 2021. Now, the demand for such equipment is on track to grow exponentially. Development Of New Biotech Coating In Orthopedic Medical Devices.
Medico Reach
OCTOBER 17, 2022
million by 2028. Quite recently, the Food and Drug Administration (FDA) marked a historical moment when it approved Patient Specific Talus Spacer 3D-printed implants in 2021. Now, the demand for such equipment is on track to grow exponentially. Development Of New Biotech Coating In Orthopedic Medical Devices.
pharmaphorum
SEPTEMBER 13, 2022
Thanks to the dedicated efforts of doctors, patients, carers, and healthcare professionals, people diagnosed with blood cancer are now living longer, with a steady stream of more effective treatments entering the market each year. 2001– FDA green lights revolutionary treatments. 2002 – Emergence of CAR-T therapy.
Expert insights. Personalized for you.
52 
Let's personalize your content